The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The efficacy and safety of anlotinib in refractory colorectal cancer: A double-blinded, placebo controlled, randomized phase III ALTER0703 trial.
 
Yihebali Chi
No Relationships to Disclose
 
Yongqian Shu
No Relationships to Disclose
 
Yi Ba
No Relationships to Disclose
 
Yuxian Bai
No Relationships to Disclose
 
Baoli Qin
No Relationships to Disclose
 
Xiuwen Wang
No Relationships to Disclose
 
Jianping Xiong
No Relationships to Disclose
 
Nong Xu
No Relationships to Disclose
 
Helong Zhang
No Relationships to Disclose
 
Jianming Xu
No Relationships to Disclose
 
Ying Cheng
No Relationships to Disclose
 
Jifeng Feng
No Relationships to Disclose
 
Chunhong Hu
No Relationships to Disclose
 
Yigui Chen
No Relationships to Disclose
 
Zhendong Chen
No Relationships to Disclose
 
Jufeng Wang
No Relationships to Disclose
 
Chenxue Dang
No Relationships to Disclose
 
Jianqiang Cai
No Relationships to Disclose